financetom
Business
financetom
/
Business
/
Update: Proxy Adviser Reportedly Urges Hess Shareholders to Abstain From Vote on Acquisition by Chevron
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Update: Proxy Adviser Reportedly Urges Hess Shareholders to Abstain From Vote on Acquisition by Chevron
May 13, 2024 12:02 PM

02:38 PM EDT, 05/13/2024 (MT Newswires) -- (Updates with details throughout)

Proxy adviser Institutional Shareholders Services recommended that Hess (HES) shareholders abstain from voting on Chevron's ( CVX ) proposed $53 billion acquisition of the company, according to media reports.

The firm made its recommendation based on a number of factors, including the possible delay in deal closing as a result of the arbitration initiated by Exxon Mobil ( XOM ) over Hess' 30% stake in the Stabroek oilfield in Guyana.

Exxon Mobil ( XOM ), which is the operator of the oilfield with a 45% stake in the block, is looking to establish its right of first refusal over Hess' 30% stake.

Hess' ownership in Stabroek is a key focus of Chevron's ( CVX ) purchase of the company, and Chevron ( CVX ) previously warned the merger could collapse if no resolution is reached between the parties.

China's Cnooc, which also owns a stake in Stabroek, also previously filed an arbitration claim against Hess over the stake.

The ISS also reportedly echoed concerns by some Hess shareholders over the value Chevron ( CVX ) has placed to buy the business.

Hess shareholders are due to meet May 28 to vote on Chevron's ( CVX ) takeover.

Hess and Chevron ( CVX ) did not immediately respond to requests for comment from MT Newswires.

Price: 163.86, Change: -1.96, Percent Change: -1.18

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
US FDA approves Gilead's twice-yearly injection for HIV prevention
US FDA approves Gilead's twice-yearly injection for HIV prevention
Jun 18, 2025
June 18 (Reuters) - The U.S. Food and Drug Administration on Wednesday approved Gilead Sciences' ( GILD ) lenacapavir, a twice-yearly injection, for preventing HIV infection in adults and adolescents. Gilead said the drug will be sold under the brand name Yeztugo. ...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Uber, Lyft Shares Slide As Waymo Applies For NYC Testing Permit
Uber, Lyft Shares Slide As Waymo Applies For NYC Testing Permit
Jun 18, 2025
Uber Inc. and Lyft Inc. ( LYFT ) shares are trading lower Wednesday following reports that Waymo applied for a New York City testing permit. What To Know: Bloomberg reported Wednesday that Waymo, the autonomous vehicle subsidiary of Alphabet Inc ( GOOG )., has applied for a permit to test its self-driving taxis in New York City. Waymo has requested...
Waymo brings its cars to NYC for testing, applies for autonomous driving permit
Waymo brings its cars to NYC for testing, applies for autonomous driving permit
Jun 18, 2025
(Reuters) -Alphabet's self-driving unit Waymo said on Wednesday its vehicles will be back in New York City next month for autonomous testing, as it continues to scale operations in the U.S. The race to deploy robotaxis is picking up pace as Waymo expands testing and Tesla prepares to begin limited trials of its autonomous taxi service with as few as...
Copyright 2023-2026 - www.financetom.com All Rights Reserved